FcRn Inhibitor Therapies in Neurologic Diseases.

Autor: Alfaidi N; Ellen and Martin Prosserman Centre for Neuromuscular Diseases, Toronto General Hospital, University Health Network, University of Toronto, 5EC-309, TGH 200 Elizabeth St, Toronto, ON, M5G 2C4, Canada., Karmastaji S; Ellen and Martin Prosserman Centre for Neuromuscular Diseases, Toronto General Hospital, University Health Network, University of Toronto, 5EC-309, TGH 200 Elizabeth St, Toronto, ON, M5G 2C4, Canada., Matic A; Ellen and Martin Prosserman Centre for Neuromuscular Diseases, Toronto General Hospital, University Health Network, University of Toronto, 5EC-309, TGH 200 Elizabeth St, Toronto, ON, M5G 2C4, Canada., Bril V; Ellen and Martin Prosserman Centre for Neuromuscular Diseases, Toronto General Hospital, University Health Network, University of Toronto, 5EC-309, TGH 200 Elizabeth St, Toronto, ON, M5G 2C4, Canada. vera.bril@utoronto.ca.

Publikováno v: CNS drugs [CNS Drugs] 2024 Jun; Vol. 38 (6), pp. 425-441. Date of Electronic Publication: 2024 May 09.

Case report: Rapid clinical improvement of anti-HMGCR immune-mediated necrotizing myopathy treated with efgartigimod.

Autor: Zeng, Quantao, Chen, Kai, Zeng, Li, Xu, Lixia, Tan, Song

Publikováno v: Frontiers in Immunology; 2024, p1-6, 6p